Page last updated: 2024-08-21

hydrazine and Lymphoma, B-Cell

hydrazine has been researched along with Lymphoma, B-Cell in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arribas, AJ; Bertoni, F; Cascione, L; Curti, E; Gaudio, E; Priebe, V; Rossi, D; Spriano, F; Stathis, A; Tarantelli, C; Zhang, L; Zucca, E	1
Argueta, C; Bastard, C; Bertrand, P; Bohers, E; Camus, V; Copie-Bergman, C; Cornic, M; Damotte, D; Delarue, R; Dubois, S; Dyer, MJ; Fest, T; Figeac, M; Gaulard, P; Haioun, C; Jais, JP; Jardin, F; Landesman, Y; Lemasle, E; Lemonnier, F; Leroy, K; Maingonnat, C; Mareschal, S; Milpied, N; Moeller, P; Molina, TJ; Ochmann, M; Pelletier, L; Picquenot, JM; Pujals, A; Salles, G; Sola, B; Stamatoullas, A; Sundstrom, C; Tilly, H; Traverse-Glehen, A; Viailly, PJ	1

Studies

Arribas, AJ; Bertoni, F; Cascione, L; Curti, E; Gaudio, E; Priebe, V; Rossi, D; Spriano, F; Stathis, A; Tarantelli, C; Zhang, L; Zucca, E

Argueta, C; Bastard, C; Bertrand, P; Bohers, E; Camus, V; Copie-Bergman, C; Cornic, M; Damotte, D; Delarue, R; Dubois, S; Dyer, MJ; Fest, T; Figeac, M; Gaulard, P; Haioun, C; Jais, JP; Jardin, F; Landesman, Y; Lemasle, E; Lemonnier, F; Leroy, K; Maingonnat, C; Mareschal, S; Milpied, N; Moeller, P; Molina, TJ; Ochmann, M; Pelletier, L; Picquenot, JM; Pujals, A; Salles, G; Sola, B; Stamatoullas, A; Sundstrom, C; Tilly, H; Traverse-Glehen, A; Viailly, PJ

Other Studies

2 other study(ies) available for hydrazine and Lymphoma, B-Cell

Article	Year
The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents. Haematologica, 2019, Volume: 104, Issue:7 Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Drug Synergism; Humans; Hydrazines; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Niacinamide; Piperidines; Pyrazoles; Pyrimidines; Sulfonamides; Triazoles; Tumor Cells, Cultured	2019
Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma. American journal of hematology, 2016, Volume: 91, Issue:9 Topics: Acrylates; Active Transport, Cell Nucleus; Adolescent; Adult; Aged; Biomarkers; Cell Line, Tumor; Exportin 1 Protein; Female; Gene Expression Profiling; Hodgkin Disease; Humans; Hydrazines; Karyopherins; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Mutation; Receptors, Cytoplasmic and Nuclear; Sequence Analysis, DNA; Triazoles; Young Adult	2016

Article

Year

The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents.

Haematologica, 2019, Volume: 104, Issue:7

Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Drug Synergism; Humans; Hydrazines; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Niacinamide; Piperidines; Pyrazoles; Pyrimidines; Sulfonamides; Triazoles; Tumor Cells, Cultured

2019

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.

American journal of hematology, 2016, Volume: 91, Issue:9

Topics: Acrylates; Active Transport, Cell Nucleus; Adolescent; Adult; Aged; Biomarkers; Cell Line, Tumor; Exportin 1 Protein; Female; Gene Expression Profiling; Hodgkin Disease; Humans; Hydrazines; Karyopherins; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Mutation; Receptors, Cytoplasmic and Nuclear; Sequence Analysis, DNA; Triazoles; Young Adult

2016